These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Ongoing 2007-000841-36 Multicenter, randomized, double-blind, placebo-controlled parallel group study to demonstrate the efficacy (quality of life) and safety of the standardized mistletoe extract PS76A2 during chemotherapy... not-yet-due
Completed, but no date Terminated 2007-001501-13 An open, randomized study to investigate the plasma and synovial fluid concentrations of glucosamine before and after repeated doses of crystalline glucosamine sulfate administered as oral soluble pow... bad-data
Completed, but no date Terminated 2007-003478-25 “The effect of acute and chronic administration of the CCK1 receptor antagonist Dexloxiglumide (CR2017) on 24-h pH metry, LES motor and symptoms’ pattern, in patients with gastroesophageal reflux dise... bad-data
Not reported 2008-003875-35 Comparative study of efficacy and safety of GO-ON and Hyalgan in patients with symptomatic osteoarthritis of the knee. 2009-11-17 due-trials
Ongoing 2010-019505-42 ESTUDIO ALEATORIZADO, DOBLE CIEGO Y CONTROLADO CON PLACEBO PARA EVALUAR LA EFICACIA Y SEGURIDAD DE LEGALON SIL EN EL TRATAMIENTO DE LA RECURRENCIA DE VHC EN EL INJERTO DE PACIENTES SOMETIDOS A UN TRAS... not-yet-due
Completed, but no date Terminated 2010-020146-10 A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO INVESTIGATE THE EFFICACY AND SAFETY OF LEGALON SIL FOR THE TREATMENT OF HCV RECURRENCE IN STABLE LIVER TRANSPLANTED PATIENTS. STUDIO RANDOMIZ... bad-data
Completed, but no date Terminated 2010-020660-37 A Multicenter, randomized, double blind, double dummy, placebo controlled, parallel group, phase II study on the prevention of mucositis by CR3294, orally administered for 5 days in haematological pat... bad-data
Completed, but no date Terminated 2012-000281-38 A Randomized, Controlled Study To Investigate The Efficacy, Safety And Pharmacokinetics Of Legalon® Sil, Alone Or In Combination With Ribavirin, For The Prevention Of Recurrent Hepatitis C In Liver Tr... bad-data
Not reported Terminated 2013-000245-39 Rescue effect of daily infusions with Legalon® SIL in Hepatitis C Virus-infected patients who are incomplete responders to standard pegylated interferon/ribavirin (dual therapy) or pegylated interfero... 2014-03-14 due-trials
Completed, but no date 2013-004469-15 Effect of CCK antagonists in Obstructive Sleep Apnea (OSA) syndrome. A randomized, double-blind, cross-over study bad-data
Reported results 2015-001136-37 A randomized, double-blind, parallel group, placebo-controlled study to evaluate the efficacy, safety and tolerability of CR4056 administered for 2 weeks in patients with osteoarthritis of the knee wi... 2016-07-05 due-trials
Reported results 2016-004834-11 A randomized, double blind, placebo-controlled, dose response, phase II, multicentre trial to evaluate the efficacy, safety and pharmacokinetics of oral CR6086 administered at the doses of 30, 90 or 1... 2019-01-08 due-trials
Reported results 2017-004655-23 A randomized, double-blind, active- and placebo-controlled, parallel group, single dose, multicentre study to assess the analgesic effect of CR4056 in postoperative dental pain 2019-07-02 due-trials
Exempt 2020-002435-29 An open-label, single-arm, phase Ib/IIa trial to evaluate the safety and efficacy of the EP4 receptor antagonist CR6086 in combination with the PD-1 inhibitor balstilimab (AGEN2034), in patients with ... not-yet-due

Related organisations

Over time organisations can merge, or split.

We think Rottapharm is now effectively part of Viatris.